Li C. is an experienced leader in the biopharmaceutical industry with over thirteen years of expertise in areas including process development, process validation, and analytical data analysis. They have held various roles at companies such as Bristol Myers Squibb, bluebird bio, and Kiniksa Pharmaceuticals, where they led cross-functional teams and managed technology transfers for late-stage programs. Currently, Li serves as the Director of CMC and MSAT at Compass Therapeutics Inc., continuing to drive innovation in biopharmaceutical processes. Li's educational background includes a research assistant role at the University of Massachusetts, where they contributed to nanotechnology projects.
This person is not in any teams
This person is not in any offices